AltaBioscience stock a selection of individual histone peptides and 5 different histone peptide sets. The peptide sequences are derived from human histones H2A, H2B, H3 and H4 and include a range of modified amino acids.
AltaBioscience has provided custom synthesis of histone peptides from human H2a, H2b, H3 and H4 regions for many years, having collaborated with the original scientist who developed the idea for histone assays.
Suitable for both monoclonal antibody production and polyclonal antibody production, our peptide synthesis experts can assist with peptide antigen design using our epitope design software thereby suggesting antigenic peptide regions likely to provide the best immune response.
Although there are ways to combat influenza viruses, they have evolved to mutate frequently in order to evade the host’s immune system.
Protein and peptide (epitope) tag sequences are attached to proteins to facilitate easy detection and purification of expressed proteins.
In this article, we discuss methods for generating custom antibodies using peptide antigens including peptide antigen design considerations and options for generating antigenic peptides. In general, synthetic peptides are too small to elicit an immunogenic response.
This article is the 3rd in a series on the synthesis of peptides. It looks at solubilising peptides and peptide storage. Peptides are supplied as lyophilised materials, which are regarded as stable compounds for shipping purposes.
Our instrumentation allows for single batch synthesis of up to 576 small scale peptides in one operation, as well as individual peptides in multigram amounts.
In this article we detail some of the design considerations we use in peptides synthesis. This article is available to view here.
Exenatide is a synthetic 39-amino acid peptide used in the treatment of insulin-treated type 2 diabetes. This GLP-1 analogue is resistant to enzymatic degradation unlike the human Glucagon-Like Peptide-1 (GLP-1) peptide.